Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Biose

Biose
1956 FOUNDED
M&A STATUS
51-60 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of therapeutic applications. The company develops innovative therapeutic applications for probiotics under pharmaceutical guidelines.

Website
Formerly Known As
Probionov
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Primary Industry
Distributors/Wholesale
Other Industries
Pharmaceuticals
Primary Office
  • Parc Technologie de La Pardieu
  • 7 Avenue Léonard de Vinci
  • 63000 Clermont-Ferrand
  • France

+33 04 00 00 00 00

Biose Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Biose‘s full profile, request access.

Request full access to PitchBook

Biose Executive Team (1)

Name Title Board
Seat
Contact
Info
Stanislas Desjonqueres Chief Executive Officer & Chairman

Biose Board Members (1)

Name Representing Role Since Contact
Info
000000000 000000000000 Biose Chief Executive Officer & Chairman 000 0000